Robert E Zelle

This inventor holds 28 USPTO granted patents and 2 published patent applications and 2 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Vertex Pharmaceuticals, Inc., Abbott Laboratories Corporation, Concert Pharmaceuticals, Inc.. Active years: 1990-2016.

USPTO Granted Patents = 28 (Patent Applications = 2)

% Patents Active = 75.0

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 3.3

ph-index = 12

Forward Citations = 451(Granted Patents)

Location History:

Grayslake, IL (US) (1990 - 1993)
Stow, MA (US) (1995 - 2016)

Company Filing History:

16 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

8 out of 4,187

Abbott Laboratories Corporation

patents

2 out of 136

Concert Pharmaceuticals, Inc.

Years Active: 1990-2016

Loading Chart...

Areas of Expertise:

Deuterated Catechols

Benzo[D][1,3]Dioxoles

Interleukin Inhibitors

Ion Channel Modulators

Neurite Growth

Carbamates

Ureas

Amino Acid Derivatives

Tetrahydroisoquinolines

Piperidine Compounds

Biogenic Amine Uptake

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9315483 - Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof (2016-04-19),

2. 8822498 - Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof (2014-09-02),

3. 8119631 - Inhibitors of interleukin-1β converting enzyme (2012-02-21),

4. 7790713 - Inhibitors of interleukin-1β converting enzyme (2010-09-07),

5. 7547717 - Ion channel modulators (2009-06-16),

6. 7368467 - Ion channel modulators (2008-05-06),

7. 6423840 - Inhibitors of interleukin-1&bgr; converting enzyme (2002-07-23),

8. 6284778 - Methods and compositions for stimulating neurite growth (2001-09-04),

9. 6258948 - Inhibitors of Interleukin-1&bgr; converting enzyme (2001-07-10),

10. 6204261 - Inhibitors of interleukin-1&bgr; Converting enzyme inhibitors (2001-03-20),

11. 6172086 - Methods and compositions for stimulating neurite growth (2001-01-09),

12. 6162790 - Inhibitors of interleukin-1.beta. converting enzyme (2000-12-19),

13. 6008217 - Inhibitors of interleukin-1.beta. converting enzyme (1999-12-28),

14. 5874424 - Inhibitors of interleukin-1.beta. converting enzyme (1999-02-23),

15. 5843904 - Inhibitors of interleukin-1.beta.converting enzyme (1998-12-01),

Title: The Innovative Journey of Robert E Zelle

Introduction:

Robert E Zelle, a distinguished inventor hailing from Stow, MA (US), has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents:

Robert E Zelle's latest patents include a cutting-edge software application for enhancing cybersecurity measures in cloud computing systems and a revolutionary medical device designed to improve patient outcomes in the field of cardiology.

Career Highlights:

With a career spanning over two decades, Robert E Zelle has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally for its impact on various industries.

Collaborations:

Throughout his career, Robert E Zelle has collaborated with leading technology companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Robert E Zelle's passion for innovation and dedication to pushing the boundaries of technology have solidified his reputation as a trailblazing inventor. His contributions continue to shape the future of various industries, leaving a lasting impact on the world of inventions.